PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Published:2024-10 Issue: Volume:210 Page:114268
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Abu Sabbah Tanja,Theurer Sarah,Baba Hideo Andreas,Lueong Smiths,Rashidi-Alavijeh Jassin,Hilser Thomas,Zaun Yasmin,Metzenmacher Martin,Pogorzelski Michael,Virchow Isabel,Pretzell Ina,Kostbade Karina,Treckmann Jürgen,Wiesweg Marcel,Schuler Martin,Kasper Stefan,Zaun Gregor

Funder

Universität Duisburg-Essen

Roche

Publisher

Elsevier BV

Reference16 articles.

1. CUP syndrome-metastatic malignancy with unknown primary tumor;Zaun;Dtsch Arztebl Int,2018

2. Cancer of unknown primary: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Krämer;Ann Oncol,2023

3. Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies;Zaun;Eur J Cancer,2024

4. Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary;Posner;J Immunother Cancer,2023

5. Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary;Tanizaki;Ann Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP